Over at Genetic Future, Daniel MacArthur writes about the promises and challenges of big genetics. This year, he writes, we'll see major data releases from several large-scale projects, including the 1,000 Genomes Project and the Cancer Genome Atlas, and disease genetics consortia such as the Wellcome Trust Case Control Consortium, GIANT, and dozens of other groups. He argues that big genetics studies will continue to lead to smaller ones, and the key point in the continuing success of big genetics is free access to the data. "Anything that interferes with open data access is a threat to the research community as a whole -- so we need to be wary both of an excessive focus on commercialisation within academia, and of well-meaning but excessive attempts to control the flow of data."
Bigtime for Big Genetics
Jan 15, 2009